Skip to main content

Table 1 Studies describing the effects on calcium balance and iPTH in RCA CRRT

From: Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review

Author

Van der Voort (25)

Brain (26)

Zheng (27)

Boer (28)

Raimundo (32)

Modality

CVVH

CVVHDF

CVVH

CVVH

CVVHD

Follow-up (hours)

48

24

24

24

48

Numbers included

9 patients in nadroparin vs 11 in citrate

26 heparin, 22 citrate circuits in 13 patients

20 patients in discovery cohort, 97 in validation cohort

17 high-dose, 18 low-dose citrate

30 patients

Comparison

Nadroparin vs citrate

Citrate vs heparin

Two-phase citrate model

High-dose vs low-dose citrate

Citrate only

Citrate dose (mmol/L)

2.92

2.42

4.0

4.88 vs 3.08

4.0

Systemic iCa (mmol/L)

0.8–1.0

0.8–1.1

1.0–1.2

 > 1.0

1.12–1.2

Ca balance

Negative compared to nadroparin

− 4.01 mmol/h vs + 0.24/h

− 6.1 mmol/h

− 0.41 vs -0.05 mmol/h

–

Ca balance in citrate group including extra Ca

–

− 1.12 mmol/h

 > 0

 + 0.69 vs + 0.19 mmol/h

–

iPTH (pg/ml)

     

Baseline

28

–

–

222

66.5

24 h

42.3

–

–

162

88.3

48 h

30.0

–

–

–

85

Remarks

Calcium balance negative both with/without enteral feeding; non- randomized study

No enteral feeding Ca intake or loss via residual diuresis calculated

Study defining two-phase calcium compensation model when initiating RCA, only circuit and parenteral intake

Initial Ca balance including Ca compensation algorithm on 100%, Physician ordered calcium added

Designed to study effect on iPTH of keeping systemic iCa within physiological range during RCA CVVHD

  1. CVVH continuous veno-venous hemofiltration, CVVHDF continuous veno-venous hemodiafiltration, CVVHD continuous veno-venous hemodialysis, iPTH intact parathyroid hormone